Efinaconazole
Back to searchMolecule Structure
Scientific Name
Efinaconazole
Description of the Drug
Efinaconazole is an antifungal agent used to treat onychomycosis, a fungal infection of the nail.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB09040
http://www.drugbank.ca/drugs/DB09040
Brand Name(s)
Jublia
Company Owner(s)
Acrux Dds Pty Ltd, Bausch Health Americas Inc, Padagis Us Llc, Aurobindo Pharma Ltd, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Lanosterol 14-alpha demethylase | SINGLE PROTEIN | INHIBITOR | CHEMBL3307221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL300738 | |
| WDI | DR9700030 | |
| DrugBank | DB09040 | |
| PubChem: Thomson Pharma | 14754104 | |
| PubChem | 489181 | |
| Nikkaji | J1.186.659J | |
| EPA CompTox Dashboard | DTXSID40167787 | |
| DrugCentral | 4874 | |
| ChemicalBook | CB21313343 | |
| GSRS | e2c5a81e-2017-4611-8f72-189ed62ace8b | |
| rxnorm | JUBLIA | EFINACONAZOLE |
| ChEBI | 82718 | |
| ZINC | ZINC000000006251 |
